Intellectual Property India Publishes Patent Application for 'Ccl20 Promoter-Regulated Gene Expression' Filed by Lung Biotechnology Pbc

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097939 A) filed by Lung Biotechnology Pbc, Maryland, U.S.A., on Oct. 10, for 'ccl20 promoter-regulated gene expression.'

Inventor(s) include Exline, Colin.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to CCL20 promoters derived from the regulatory region of the CCL20 gene that stimulate gene expression in response to inflammation. These CCL20 promoters, which can be stimulated by an endogenous or exogenous cytokine, can be used to control the timing of the expression of a heterologous gene. The present dis...